Radiotherapy is a medical treatment that uses high doses of radiation to target and destroy cancer cells while minimizing damage to surrounding healthy tissue. It operates on the principle that radiation disrupts the DNA of rapidly dividing cells, leading to cell death or inhibiting their ability to multiply. Radiotherapy can be administered externally through machines that direct radiation beams at the tumor, or internally via radioactive sources placed close to or within the tumor. It is commonly used in combination with other cancer treatments, such as surgery and chemotherapy, to enhance therapeutic outcomes. The effectiveness and side effects of radiotherapy can vary based on the type and stage of cancer, as well as individual patient factors.
The radiotherapy market in India, Nepal, Bangladesh, and Sri Lanka is driven by several key factors, including the rising incidence of cancer due to lifestyle changes and an aging population, which increases the demand for advanced treatment modalities. In addition, improvements in healthcare infrastructure and increased government and private investment in oncology services are enhancing accessibility to radiotherapy. The growing awareness of cancer treatment options and advancements in radiotherapy technology, such as precision radiotherapy and innovative delivery systems, are further propelling market growth. Moreover, collaborations between public and private sectors to expand healthcare facilities and enhance treatment capabilities contribute significantly to the radiotherapy landscape in these countries, addressing both clinical needs and the rising burden of cancer.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/india-nepal-bangladesh-and-sri-lanka-radiotherapy-market
Data Bridge Market Research analyzes that the India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is expected to grow at a CAGR of 12.9% in the forecast period of 2024 to 2031 and is expected to reach USD 273.09 million by 2031 from USD 116.75 million in 2023. The growing prevalence of cancer disease is projected to propel the market growth.
Key Findings of the Study
Evolving Role of India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Differentiation
The incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Thousand, and Pricing in USD
|
|
Segments Covered
|
By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others)
|
|
Countries Covered
|
India, Nepal, Bangladesh, and Sri Lanka
|
|
Market Players Covered
|
Elekta (Sweden), General Electric Company (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hitachi, Ltd. (Japan), and Siemens Healthcare GmbH (Germany)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Segment Analysis
The India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is categorized into five notable segments which are on the basis of product and services, type, application, end user, and distribution channel.
- On the basis of product and services, India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is segmented into Services, Product, Software
In 2024, the services segment of the product and services segment is expected to dominate the market
In 2024, the Services segment is expected to dominate the market with a market share of 77.04% due to the increasing demand for personalized patient care, ongoing maintenance, and technological advancements that require expert support and training..
- On the basis of type, India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others
In 2024, the external-beam radiation therapy segment of the product segment is expected to dominate the market
In 2024, the external-beam radiation therapy segment is expected to dominate the market with a market share of 77.04% due to its effectiveness in treating a wide range of cancers and its ability to deliver precise doses while minimizing damage to surrounding tissues.
- Based on application, India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others.
- Based on end user, India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is segmented into hospitals, radiation therapy centers, specialty clinics, and others
- Based on distribution channel, India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market is segmented into direct tenders, third party distributors, and others
Major Players
Data Bridge Market Research Analyses Elekta (Sweden), General Electric Company (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hitachi, Ltd. (Japan), Siemens Healthcare GmbH (Germany) as major market players in this market.
Market Development
- In May 2020, Elekta AB (PUB) announced that they have launched their new product Leksell Gamma Knife which is a next-generation treatment optimizer for intracranial stereotactic radiosurgery. After launching a new product company enhanced its product portfolio and generates adequate revenue.
- In April 2020, Elekta AB (PUB) announced that they have launched Geneva, which is the first universal gynecological applicator for brachytherapy. These are the solutions that are designed to meet the real-world needs of the front line of cancer therapy. After launching a new product company enhanced its product portfolio and generates adequate revenue.
- In October 2021, General Electric Company presented innovative multi-modality radiation therapy solutions which are designed to improve patient-centered care and advance the practice of precision medicine. Through this presentation, the company has strengthened its role as a core partner in cancer treatment and diagnosis.
For more detailed information about the India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market report, click here- https://www.databridgemarketresearch.com/es/reports/india-nepal-bangladesh-and-sri-lanka-radiotherapy-market
